Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Adherium.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks are standing strong this morning
Health & Biotech
Check up: Enthusiasm rather than news is moving health stocks
Health & Biotech
Health: GTG back in with breast cancer, hopes to start sales next year
News
Corporate: Digital Wine Ventures tells shareholders it’s beginning to taste cash flows from WINEDEPOT
Health & Biotech
Health: HeraMED’s heart rate monitor just got clearance to pop into the US market; it’s now doubled in a week
Health & Biotech
Check-up: Novita shareholders are enjoying a fast-paced ride
Health & Biotech
Health: G Medical is close to listing on the NASDAQ and Hong Kong exchanges
Tech
It’s New Zealand’s national day, but most Kiwi small caps won’t be celebrating
Health & Biotech
Is asthma the next illness to watch?
Health & Biotech
Four key factors impacting health and med-tech stocks in 2018
News
Lunchtime small cap wrap: who’s jumping higher and who’s falling
Health & Biotech
Adherium shares puff up 50pc on US approval for smart asthma inhaler
News
Lunchtime small cap wrap: who’s flying high and who’s full of hot air
Tech
How to power-up your portfolio with ASX video game stocks
Health & Biotech
Some Aussie biotechs are getting their cyber sec on — but a lot aren’t
Health & Biotech
